◎ 국내학회지 발표논문
1. Adherence to follow-up examination after positive fecal occult blood test results affects colorectal cancer mortality: A Korea population-based cohort study Digestive and Liver Disease 53 2021; 53(5): 631-638

2. miRNAs as potential biomarkers for the progression of gastric cancer inhibit CREBZF and regulate migration ofgastric adenocarcinoma cells International Journal of Medical Sciences 2020; 17(6): 693-701.

3. Safety of esophagogastroduodenoscopy guided forceps biopsy and the feasibility of esophagogastroduodenoscopy for evaluation of hypopharyngeal cancer 2019; 8;19(1):105

4. Potential miRNA-target interactions for the screening of gastric carcinoma development in gastric adenoma/dysplasia International Journal of Medical Sciences 2018; 15(6): 610-616.

5. Endoscopic management of anastomotic leakage after gastrectomy for gastric cancer: how efficacious is it? Scand J Gastroenterol. 2013 Jan;48(1):111-8.

6. Is esophagogastroduodenoscopy necessary in patients with positive fecal occult blood tests and negative colonoscopy? Scand J Gastroenterol. 2013 ;48(6):657-62

7. Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesions. Endoscopy 2010; 42:1–7

8. Rebamipide May Be Comparable to H2 Receptor Antagonist in Healing Iatrogenic Gastric Ulcers Created by Endoscopic Mucosal Resection: A Prospective Randomized Pilot Study. J Korean Med Sci 2010; 25: 583-8